Abou-Khalil BW. Update on antiseizure medications 2022. CONTINUUM Lifelong Learn Neurol. 2022;28(2):500–35.

Article  Google Scholar 

Fukada C, Kohler JC, Boon H, et al. Prescribing gabapentin off label: perspectives from psychiatry, pain and neurology specialists. Can Pharm J (Ott). 2012;145(6):280-2841e1.

Article  PubMed  Google Scholar 

Schaffer AL, Busingye D, Chidwick K, et al. Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study. BJGP Open. 2021. https://doi.org/10.3399/bjgpopen20X101120.

Article  PubMed  Google Scholar 

Kaye AD, Granier AL, Garcia AJ, et al. Non-opioid perioperative pain strategies for the clinician: a narrative review. Pain Ther. 2020;9(1):25–39.

Article  PubMed  PubMed Central  Google Scholar 

Athavale A, Murnion B. Gabapentinoids: a therapeutic review. Aust Prescr. 2023;46(4):80–5.

Article  PubMed  PubMed Central  Google Scholar 

Department of Health and Aged Care. The Pharmaceutical Benefits Scheme. 2024 (cited 15-08-2024); Available from: https://www.pbs.gov.au/medicine/item/1834M-4592Q.

Olopoenia A, Camelo-Castillo W, Qato DM, et al. Adverse outcomes associated with concurrent gabapentin, opioid, and benzodiazepine utilization: a nested case-control study. Lancet Reg Health Am. 2022;13:100302.

PubMed  PubMed Central  Google Scholar 

Guy S, Mehta S, Leff L, et al. Anticonvulsant medication use for the management of pain following spinal cord injury: systematic review and effectiveness analysis. Spinal Cord. 2014;52(2):89–96.

Article  CAS  PubMed  Google Scholar 

Wiffen PJ, Derry S, Moore RA. Lamotrigine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2013;2013(12):CD006044.

PubMed  PubMed Central  Google Scholar 

Gill D, Derry S, Wiffen PJ, et al. Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2011;2011(10):CD009183.

PubMed  PubMed Central  Google Scholar 

Nielsen S, Buchbinder R, Pearce C, et al. Cohort profile: using primary care data to understand opioid prescribing, policy impacts and clinical outcomes (OPPICO) in Victoria, Australia. BMJ Open. 2023;13(5): e067746.

Article  PubMed  PubMed Central  Google Scholar 

BioPortal. SNOMED CT. 2024 [cited 2024 10 July]; Available from: https://bioportal.bioontology.org/ontologies/SNOMEDCT.

Von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–9.

Article  Google Scholar 

Ashworth J, Bajpai R, Muller S, et al. Trends in gabapentinoid prescribing in UK primary care using the clinical practice research datalink: an observational study. Lancet Reg Health Eur. 2023;27:100579.

Article  PubMed  PubMed Central  Google Scholar 

Dokkedal-Silva V, Berro LF, Galduróz JCF, et al. Clonazepam: indications, side effects, and potential for nonmedical use. Harv Rev Psychiatr. 2019;27(5):279–89.

Article  Google Scholar 

Pharmaceutical Benefits Advisory Committee, Drug utilisation sub-committee (DUSC) meeting, Pregabalin: 12 Month predicted versus actual analysis 2014.

Pharmaceutical Benefits Advisory Committee. Drug utilisation sub-committee (DUSC) opioid analgesics. 2020; Available from: https://www.pbs.gov.au/info/industry/listing/participants/public-release-docs/2020-02/opioid-analgesics.

Peckham AM, Evoy KE, Ochs L, et al. Gabapentin for off-label use: evidence-based or cause for concern? Subst Abuse Res Treat. 2018;12:1178221818801311.

Article  Google Scholar 

Wallach JD, Ross JS. Gabapentin approvals, off-label use, and lessons for postmarketing evaluation efforts. JAMA. 2018;319(8):776–8.

Article  PubMed  Google Scholar 

Nielsen S, Picco L, Russell G, et al. Changes in opioid and other analgesic prescribing following voluntary and mandatory prescription drug monitoring program implementation: a time series analysis of early outcomes. Int J Drug Policy. 2023;117: 104053.

Article  PubMed  Google Scholar 

Goodman CW, Brett AS. A clinical overview of off-label use of gabapentinoid drugs. JAMA Intern Med. 2019;179(5):695–701.

Article  PubMed  Google Scholar 

Nielsen S, Gisev N, Leung J, et al. Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non-cancer pain: a five-year prospective cohort study. Br J Clin Pharmacol. 2021;87(8):3092–104.

Article  PubMed  Google Scholar 

Cairns R, Schaffer AL, Ryan N, et al. Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisonings. Addict. 2019;114(6):1026–34.

Article  Google Scholar 

Evoy KE, Sadrameli S, Contreras J, et al. Abuse and misuse of pregabalin and gabapentin: a systematic review update. Drugs. 2021;81:125–56.

Article  CAS  PubMed  Google Scholar 

Meaadi J, Obara I, Eldabe S, et al. The safety and efficacy of gabapentinoids in the management of neuropathic pain: a systematic review with meta-analysis of randomised controlled trials. Int J Clin Pharm. 2023;45(3):556–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li RJ, Caughey GE, Shakib S. Concomitant inpatient prescribing of strong opioids with sedatives: associations with comorbid conditions. Pharmacol Res Perspect. 2021;9(1): e00717.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tomson T, Battino D, Bromley R, et al. Management of epilepsy in pregnancy: a report from the international league against epilepsy task force on women and pregnancy. Epileptic Disord. 2019;6(6):497–517.

Article  Google Scholar 

Hollingworth SA, Symons M, Khatun M, et al. Prescribing databases can be used to monitor trends in opioid analgesic prescribing in Australia. Aust N Z J Public Health. 2013;37(2):132–8.

Article  PubMed  Google Scholar 

Lin P-ID, Daley MF, Boone-Heinonen J, et al. Comparing prescribing and dispensing data of the PCORnet common data model within PCORnet antibiotics and childhood growth study. EGEMs. 2019;7(1):11.

Article  PubMed  PubMed Central  Google Scholar 

Imai C, Hardie R-A, Franco GS, et al. Harnessing the potential of electronic general practice pathology data in Australia: an examination of the quality use of pathology for type 2 diabetes patients. Int J Med Inform. 2020;141: 104189.

Article  PubMed  Google Scholar 

RACGP, General Practice Health of the Nation 2023. The Royal Australian College of General Practitioners East Melbourne, VIC; 2023. [cited 2024 10 July]; Available from: https://www.racgp.org.au/getmedia/122d4119-a779-41c0-bc67-a8914be52561/Health-of-the-Nation-2023.pdf